Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study.
Aliment Pharmacol Ther
; 48(3): 333-339, 2018 08.
Article
de En
| MEDLINE
| ID: mdl-29920697
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Maladie de Crohn
/
Chimiothérapie d'induction
/
Ustékinumab
Type d'étude:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limites:
Adult
/
Female
/
Humans
/
Male
Langue:
En
Journal:
Aliment Pharmacol Ther
Sujet du journal:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Année:
2018
Type de document:
Article
Pays d'affiliation:
Irlande
Pays de publication:
Royaume-Uni